Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Gastric Bypass on Oral Contraceptive Pharmacokinetics
NCT01941134Phase 4Withdrawn
- Sponsor
- Johns Hopkins University
- Start
- Apr 2013
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of ethinylestradiol + levonorgestrel in contraception, sponsored by Johns Hopkins University. Primary endpoint: Serum hormone levels of Ethinyl estradiol and levonorgestrel (AUC). Planned start Apr 2013; status: withdrawn.
02
Drugs
ethinylestradiol + levonorgestrel
03
Conditions
contraception
Beyond the preview
Go deeper on NCT01941134.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01941134.